肥胖伴糖耐量异常者经吡格列酮治疗后血清脂蛋白亚类的变化
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

安徽省科技厅年度科研计划项目(10021303079)


Alteration of Plasma Lipoprotein Subclasses in Obesity People with Impaired Glucose Tolerance After Pioglitazone Treatment
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 研究肥胖伴糖耐量异常者血高密度脂蛋白(HDL)亚类分布情况以及吡格列酮干预后对血浆HDL亚类分布的影响。方法 比较40例健康人与40例肥胖伴糖耐量异常者血浆高密度脂蛋白(HDL)亚类分布,了解肥胖伴糖耐量异常者血浆HDL亚类分布特点。采用配对设计的随机分组方法,以性别作为随机配对的条件,将40例肥胖伴糖耐量异常者作为研究对象分为安慰剂组和吡格列酮组,药物干预12周后,抽取受试者空腹12 h静脉血,24 h内进行HDL各亚组分含量的测定以及对氧磷酶1(PON-1)活性的测定。分析血浆HDL亚类分布与PON-1活性的相关性。结果 肥胖伴糖耐量异常者血清HDL分布异常,HDL2a和HDL2b减低,而小颗粒的preβ1-HDL、preβ2-HDL、HDL3a升高,差异具有统计学意义(P<0.05)。与安慰剂组比较,吡格列酮组用药后12周,受试者血清HDL中HDL2a、HDL2b、PON-1显著升高,preβ1-HDL显著降低,差异具有统计学意义(P<0.05)。相关性分析显示,preβ1-HDL与PON-1呈负相关, HDL2b与PON-1呈正相关,相关性有显著性。结论 肥胖伴糖耐量异常患者血清中HDL亚类分布异常,成熟代谢过程受阻,趋向于较弱的抗动脉粥样硬化的分布趋势。吡格列酮通过改善HDL亚类的分布以及提高PON-1活性,增强了HDL抗动脉粥样硬化的作用。HDL亚类分布中成熟的大颗粒含量越高,PON-1的活性越强,抗动脉粥样硬化能力越强。

    Abstract:

    Aim To investigate the high density lipoprotein (HDL) subclasses distribution characteristics before and after the intervention of Pioglitazone in obesity people with impaired glucose tolerance. Methods The difference of plasma HDL subclass distribution was compared in 40 cases of healthy people and 40 cases of obesity people with glucose tolerance, to investigate the plasma HDL and class distribution characteristics in obesity people with impaired glucose tolerance. Using the randomized matching design method (the sex as the condition),forty men were randomized,to placebo or pioglitazone (30 mg/day) for 12 weeks. The subclasses of serum HDL were determined by two dimensional gel electrophoresis in conjunction with immunodetection method and paraoxonase-1 activity by spectrophotometric assays. The correlation between the distribution of plasma HDL subclasses and the activity of PON-1 were analyzed. Results Compared to the health group, the HDL2a and HDL2b decreased while the preβ1-HDL, preβ2-HDLand HDL3a increased significantly in obesity man with glucose tolerance. Compared to the control group, the preβ1-HDL decreased while the HDL2a and HDL2b increased and activity of PON-1 increased significantly in Pioglitazone group after 12 weeks. PON-1 is positively correlated with HDL2b,and negatively correlated with preβ1-HDL. Conclusion Obese patients with abnormal glucose tolerance handicaped the mature process of serum HDL, tended to have weaker resistance from atherosclerosis. Pioglitazone improved the distribution of HDL subclass and increased the activity of PON-1 in overweight and obese men with impaired glucose tolerance,which may help reduce the incidence of premature cardiovascular disease. The activity of PON-1 is positively correlated with mature distribution of HDL subclasses.

    参考文献
    相似文献
    引证文献
引用本文

李红旗,胡立群,章 琦,陈 莉,严 光.肥胖伴糖耐量异常者经吡格列酮治疗后血清脂蛋白亚类的变化[J].中国动脉硬化杂志,2014,22(07):701~705.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2013-09-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: